Move over Fitbit.
Cambridge startup Quanttus announced on Monday that it has raised $19 million in Series A for a new piece of wearable tech that works to give users continuous health monitoring. The round comes from local VC firm Matrix Partners and Silicon Valley-based Kholsa Ventures.
The unnamed device is now in testing, and can be used to gather critical clinical data on vital signs including heat rate, respiration and blood pressure, according to the Boston Business Journal.
The end goal for Quanttus is to be able to provide a closer, more complete look at personal health – the type of look that many people currently only get from visiting their primary care doctor once a year.
The device's details has yet to be finalized, but will likely be able to be worn in all the same locations as a Fitbit, like the wrist. The tech could be helpful in monitoring common health issues like cardiac disease, hypertension and stress.
The company imagines that the device would suit a wide variety of people like those afflicted by chronic health conditions, busy professionals, fit athletes and anyone who wants to live a healthier lifestyle.
Khosla Ventures also led the company's $3 million seed round in 2012. The firm is also an investor in West Coast-based wearables company Jawbone and Boston mobile health startup Ginger.io.
MIT-spun Quanttus launched in fall of 2012 and was founded by Shahid Azim and Richard Bijiani.
We have reached out to Quanttus and will update accordingly.
